1. Home
  2. RNW vs IMCR Comparison

RNW vs IMCR Comparison

Compare RNW & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ReNew Energy Global plc

RNW

ReNew Energy Global plc

HOLD

Current Price

$6.84

Market Cap

2.5B

Sector

Utilities

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.42

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNW
IMCR
Founded
2011
2008
Country
United Kingdom
United Kingdom
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.8B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
RNW
IMCR
Price
$6.84
$33.42
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$7.00
$66.33
AVG Volume (30 Days)
2.9M
347.6K
Earning Date
06-15-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
0.23
Revenue
N/A
$249,428,000.00
Revenue This Year
N/A
$14.57
Revenue Next Year
$11.50
$8.21
P/E Ratio
$14.63
$149.87
Revenue Growth
N/A
43.05
52 Week Low
$4.39
$27.56
52 Week High
$8.24
$40.71

Technical Indicators

Market Signals
Indicator
RNW
IMCR
Relative Strength Index (RSI) 64.64 38.29
Support Level $6.78 $31.90
Resistance Level $6.85 $35.73
Average True Range (ATR) 0.03 1.03
MACD -0.02 -0.43
Stochastic Oscillator 60.00 2.13

Price Performance

Historical Comparison
RNW
IMCR

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects. Additionally, it provides clean energy solutions and value-added energy offerings through digitalization, storage, and carbon market services that are increasingly integral to addressing climate change. The company has two reportable segments: Generation and sale of renewable power and Manufacturing of power equipment. The majority of its revenue is generated from the Generation and sale of renewable power segment, which reflects the revenue earned from its utility-scale wind energy projects, solar energy projects, and hydro energy projects. The Manufacturing of power equipment segment relates to the manufacturing of solar panels and modules. Geographically, all of its material revenues are generated from India.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: